STERIS Corp (NYSE:STE), a leading provider of sterilization and surgical equipment, has landed a $450 million contract modification from the U.S. Department of Defense (DoD). The extension builds on an existing five-year base contract, adding an additional five-year option period that will run through June 22, 2030.
Based in Mentor, Ohio, STERIS will continue supplying patient monitoring systems and capital medical equipment under the updated agreement. The contract is structured as a fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) arrangement, with economic-price-adjustment provisions to account for market changes.
This extended contract supports various branches of the U.S. military—including the Army, Navy, Air Force, and Marine Corps—as well as other federal civilian agencies. Funding will be sourced from defense working capital funds allocated across fiscal years 2025 to 2030.
The agreement is managed by the Defense Logistics Agency Troop Support in Philadelphia, Pennsylvania, ensuring the continued delivery of essential healthcare equipment for U.S. armed forces and government entities.
STERIS's ongoing collaboration with the DoD reinforces its position as a trusted supplier in the healthcare and defense sectors. The deal not only enhances the company’s government portfolio but also underscores its commitment to supporting national medical readiness and infrastructure.
With growing demand for advanced medical technologies across defense and public health sectors, STERIS is poised to further expand its role in supplying life-saving equipment to mission-critical operations. The multibillion-dollar healthcare technology firm continues to build on its reputation for quality and reliability in both commercial and government markets.
This contract extension marks another milestone for STERIS in strengthening its long-term government partnerships while contributing to the advancement of military medical capabilities.


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 



